Raymond James Trust’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$1.79M Sell
21,343
-45
-0.2% -$3.77K 0.04% 346
2024
Q2
$1.65M Buy
21,388
+4,324
+25% +$333K 0.04% 351
2024
Q1
$1.17M Buy
17,064
+96
+0.6% +$6.58K 0.03% 427
2023
Q4
$981K Buy
16,968
+1,187
+8% +$68.6K 0.03% 463
2023
Q3
$833K Buy
15,781
+2,048
+15% +$108K 0.02% 468
2023
Q2
$743K Buy
13,733
+2,244
+20% +$121K 0.02% 508
2023
Q1
$575K Buy
11,489
+349
+3% +$17.5K 0.02% 580
2022
Q4
$516K Sell
11,140
-752
-6% -$34.8K 0.02% 588
2022
Q3
$461K Sell
11,892
-2,507
-17% -$97.2K 0.02% 605
2022
Q2
$536K Buy
14,399
+293
+2% +$10.9K 0.02% 569
2022
Q1
$625K Sell
14,106
-4,286
-23% -$190K 0.02% 552
2021
Q4
$781K Sell
18,392
-1,628
-8% -$69.1K 0.02% 495
2021
Q3
$868K Buy
20,020
+10
+0% +$434 0.03% 443
2021
Q2
$856K Buy
20,010
+4,400
+28% +$188K 0.03% 439
2021
Q1
$603K Buy
15,610
+2,997
+24% +$116K 0.02% 522
2020
Q4
$453K Buy
12,613
+969
+8% +$34.8K 0.02% 582
2020
Q3
$445K Sell
11,644
-106
-0.9% -$4.05K 0.02% 528
2020
Q2
$412K Buy
11,750
+310
+3% +$10.9K 0.02% 530
2020
Q1
$373K Sell
11,440
-292
-2% -$9.52K 0.02% 478
2019
Q4
$530K Buy
11,732
+1,415
+14% +$63.9K 0.03% 447
2019
Q3
$420K Buy
10,317
+3,624
+54% +$148K 0.02% 517
2019
Q2
$287K Buy
6,693
+363
+6% +$15.6K 0.02% 642
2019
Q1
$243K Sell
6,330
-840
-12% -$32.2K 0.01% 692
2018
Q4
$253K Buy
7,170
+866
+14% +$30.6K 0.02% 626
2018
Q3
$243K Buy
+6,304
New +$243K 0.01% 725